{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:33:57Z","timestamp":1792316037500,"version":"4.4.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2006,9,4]],"date-time":"2006-09-04T00:00:00Z","timestamp":1157328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2006,9,4]],"date-time":"2006-09-04T00:00:00Z","timestamp":1157328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2006,11,1]]},"DOI":"10.1038\/sj.bmt.1705486","type":"journal-article","created":{"date-parts":[[2006,9,4]],"date-time":"2006-09-04T18:21:33Z","timestamp":1157394093000},"page":"585-592","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Autologous transplantation in elderly patients with multiple myeloma: are we asking the right questions?"],"prefix":"10.1038","volume":"38","author":[{"given":"H D","family":"Klepin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D D","family":"Hurd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,9,4]]},"reference":[{"key":"BF1705486_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM199607113350204","volume":"335","author":"M Attal","year":"1996","unstructured":"Attal M, Harousseau JL, Stoppa AM, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome. N Engl J Med 1996; 335: 91\u201397.","journal-title":"N Engl J Med"},{"key":"BF1705486_CR2","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1056\/NEJMoa022340","volume":"348","author":"JA Child","year":"2003","unstructured":"Child JA, Morgan GJ, Davies FE, Owen RG, Bell SE, Hawkins K et al. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med 2003; 348: 1875\u20131883.","journal-title":"N Engl J Med"},{"key":"BF1705486_CR3","doi-asserted-by":"publisher","first-page":"9227","DOI":"10.1200\/JCO.2005.03.0551","volume":"23","author":"JP Fermand","year":"2005","unstructured":"Fermand JP, Katsahian S, Divine M, Leblond V, Dreyfus F, Macro M et al. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe. J Clin Oncol 2005; 23: 9227\u20139233.","journal-title":"J Clin Oncol"},{"key":"BF1705486_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1046\/j.1365-2141.2001.02976.x","volume":"114","author":"A Badros","year":"2001","unstructured":"Badros A, Barlogie B, Siegel E, Morris C, Desikan R, Zangari M et al. Autologous stem cell transplantation in elderly multiple myeloma patients over the age of 70 years. Br J Haematol 2001; 114: 600\u2013607.","journal-title":"Br J Haematol"},{"key":"BF1705486_CR5","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/sj.bmt.1705307","volume":"37","author":"D O'Shea","year":"2006","unstructured":"O'Shea D, Giles C, Terpos E, Perz J, Politou M, Sana V et al. Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients. Bone Marrow Transplant 2006; 37: 731\u2013737.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705486_CR6","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1182\/blood-2004-02-0408","volume":"104","author":"A Palumbo","year":"2004","unstructured":"Palumbo A, Bringhen S, Petrucci MT, Musto P, Rossini F, Nunzi M et al. Intermediate-dose melphalan improves survival of myeloma patients aged 50 to 70: results of a randomized controlled trial. Blood 2004; 104: 3052\u20133057.","journal-title":"Blood"},{"key":"BF1705486_CR7","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/blood.V93.1.51","volume":"93","author":"DS Siegel","year":"1999","unstructured":"Siegel DS, Desikan KR, Mehta J, Singhal S, Fassas A, Munshi N et al. Age is not a prognostic variable with autotransplants for multiple myeloma. Blood 1999; 93: 51\u201354.","journal-title":"Blood"},{"key":"BF1705486_CR8","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4065\/78.1.21","volume":"78","author":"RA Kyle","year":"2003","unstructured":"Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A et al. Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 2003; 78: 21\u201333.","journal-title":"Mayo Clin Proc"},{"key":"BF1705486_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/ageing\/25.5.357","volume":"25","author":"J Blade","year":"1996","unstructured":"Blade J, Munoz M, Fontanillas M, San Miguel J, Alcala A, Maldonado J et al. Treatment of multiple myeloma in elderly people: long-term results in 178 patients. Age Ageing 1996; 25: 357\u2013361.","journal-title":"Age Ageing"},{"key":"BF1705486_CR10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1034\/j.1600-0609.2001.00301.x","volume":"66","author":"P Rodon","year":"2001","unstructured":"Rodon P, Linassier C, Gauvain JB, Benboubker L, Goupille P, Maigre M et al. Multiple myeloma in elderly patients: presenting features and outcome. Eur J Haematol 2001; 66: 11\u201317.","journal-title":"Eur J Haematol"},{"key":"BF1705486_CR11","first-page":"238","volume":"81","author":"M Clavio","year":"1996","unstructured":"Clavio M, Casciaro S, Gatti AM, Spriano M, Bonanni F, Poggi A et al. Multiple myeloma in the elderly: clinical features and response to treatment in 113 patients. Haematologica 1996; 81: 238\u2013244.","journal-title":"Haematologica"},{"key":"BF1705486_CR12","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1046\/j.1365-2141.2003.04221.x","volume":"120","author":"T Nilsson","year":"2003","unstructured":"Nilsson T, Hoglund M, Lenhoff S, Rylander L, Turesson I, Westin J et al. A pooled analysis of karyotypic patterns, breakpoints and imbalances in 783 cytogenetically abnormal multiple myelomas reveals frequently involved chromosome segments as well as significant age- and sex-related differences. Br J Haematol 2003; 120: 960\u2013969.","journal-title":"Br J Haematol"},{"key":"BF1705486_CR13","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1080\/10428190500085024","volume":"46","author":"L Mileshkin","year":"2005","unstructured":"Mileshkin L, Prince HM . The adverse prognostic impact of advanced age in multiple myeloma. Leuk Lymphoma 2005; 46: 951\u2013966.","journal-title":"Leuk Lymphoma"},{"key":"BF1705486_CR14","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/0002-9343(85)90310-9","volume":"79","author":"HJ Cohen","year":"1985","unstructured":"Cohen HJ, Bartolucci A . Age and the treatment of multiple myeloma. Southeastern Cancer Study Group experience. Am J Med 1985; 79: 316\u2013324.","journal-title":"Am J Med"},{"key":"BF1705486_CR15","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1600-0609.1989.tb00307.x","volume":"43","author":"IP Palva","year":"1989","unstructured":"Palva IP, Ahrenberg P, Ala-Harja K, Almqvist A, Hanninen A, Ilvonen M et al. Treatment of multiple myeloma in old patients. Finnish Leukaemia Group. Eur J Haematol 1989; 43: 328\u2013331.","journal-title":"Eur J Haematol"},{"key":"BF1705486_CR16","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1600-0609.1991.tb01856.x","volume":"47","author":"F Wisloff","year":"1991","unstructured":"Wisloff F, Andersen P, Andersson TR, Brandt E, Eika C, Fjaestad K et al. Has the incidence of multiple myeloma in old age been underestimated? The myeloma project of health region I in Norway I. Eur J Haematol 1991; 47: 333\u2013337.","journal-title":"Eur J Haematol"},{"key":"BF1705486_CR17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1046\/j.1365-2141.2001.02498.x","volume":"112","author":"KR Desikan","year":"2001","unstructured":"Desikan KR, Tricot G, Munshi NC, Anaissie E, Spoon D, Fassas A et al. Preceding chemotherapy, tumour load and age influence engraftment in multiple myeloma patients mobilized with granulocyte colony-stimulating factor alone. Br J Haematol 2001; 112: 242\u2013247.","journal-title":"Br J Haematol"},{"key":"BF1705486_CR18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1002\/jca.20030","volume":"19","author":"T Fietz","year":"2004","unstructured":"Fietz T, Rieger K, Dimeo F, Blau IW, Thiel E, Knauf WU . Stem cell mobilization in multiple myeloma patients: do we need an age-adjusted regimen for the elderly? J Clin Apher 2004; 19: 202\u2013207.","journal-title":"J Clin Apher"},{"key":"BF1705486_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.bmt.1700833","volume":"20","author":"SC Guba","year":"1997","unstructured":"Guba SC, Vesole DH, Jagannath S, Bracy D, Barlogie B, Tricot G . Peripheral stem cell mobilization and engraftment in patients over age 60. Bone Marrow Transplant 1997; 20: 1\u20133.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705486_CR20","first-page":"523","volume":"15","author":"AP Rapoport","year":"1995","unstructured":"Rapoport AP, DiPersio JF, Martin BA, Duerst RE, Kouides PA, Liesveld JL et al. Patients > or=age 40 years undergoing autologous or allogeneic BMT have regimen-related mortality rates and event-free survivals comparable to patients <age 40 years. Bone Marrow Transplant 1995; 15: 523\u2013530.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705486_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1038\/sj.bmt.1701232","volume":"21","author":"C Dumontet","year":"1998","unstructured":"Dumontet C, Ketterer N, Espinouse D, Neidhardt EM, Moullet I, Thieblemont C et al. Reduced progression-free survival in elderly patients receiving intensification with autologous peripheral blood stem cell reinfusion for multiple myeloma. Bone Marrow Transplant 1998; 21: 1037\u20131041.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705486_CR22","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/sj.bmt.1702188","volume":"25","author":"B Sirohi","year":"2000","unstructured":"Sirohi B, Powles R, Treleaven J, Mainwaring P, Kulkarni S, Pandha H et al. The role of autologous transplantation in patients with multiple myeloma aged 65 years and over. Bone Marrow Transplant 2000; 25: 533\u2013539.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705486_CR23","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/sj.bmt.1704288","volume":"32","author":"DE Reece","year":"2003","unstructured":"Reece DE, Bredeson C, Perez WS, Jagannath S, Zhang MJ, Ballen KK et al. Autologous stem cell transplantation in multiple myeloma patients <60 vs >\/=60 years of age. Bone Marrow Transplant 2003; 32: 1135\u20131143.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705486_CR24","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/sj.bmt.1705360","volume":"37","author":"E Jantunen","year":"2006","unstructured":"Jantunen E, Kuittinen T, Penttila K, Lehtonen P, Mahlamaki E, Nousiainen T . High-dose melphalan (200\u2009mg\/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients treated on the same protocol. Bone Marrow Transplant 2006; 37: 917\u2013922.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705486_CR25","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-2141.2006.06042.x","volume":"133","author":"S Lenhoff","year":"2006","unstructured":"Lenhoff S, Hjorth M, Westin J, Brinch L, Backstrom B, Carlson K et al. Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group. Br J Haematol 2006; 133: 389\u2013396.","journal-title":"Br J Haematol"},{"key":"BF1705486_CR26","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/sj.bmt.1703818","volume":"31","author":"E Terpos","year":"2003","unstructured":"Terpos E, Apperley JF, Samson D, Giles C, Crawley C, Kanfer E et al. Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients. Bone Marrow Transplant 2003; 31: 163\u2013170.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705486_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JCO.2005.03.7234","volume":"24","author":"T Facon","year":"2006","unstructured":"Facon T, Mary JY, Harousseau J, Huguet F, Berthou C, Grosbois B et al. Superiority of melphalan--prednisone (MP) + thalidomide (THAL) over MP and autologous stem cell transplantation in the treatment of newly diagnosed elderly patients with multiple myeloma. J Clin Oncol (Meeting Abstracts) 2006; 24: 1.","journal-title":"J Clin Oncol (Meeting Abstracts)"},{"key":"BF1705486_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/S1040-8428(00)00090-1","volume":"35","author":"M Extermann","year":"2000","unstructured":"Extermann M . Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 2000; 35: 181\u2013200.","journal-title":"Crit Rev Oncol Hematol"},{"key":"BF1705486_CR29","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/S1047-2797(96)00063-4","volume":"6","author":"R Yancik","year":"1996","unstructured":"Yancik R, Havlik RJ, Wesley MN, Ries L, Long S, Rossi WK et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 1996; 6: 399\u2013412.","journal-title":"Ann Epidemiol"},{"key":"BF1705486_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/sj.bmt.1705041","volume":"36","author":"J Alamo","year":"2005","unstructured":"Alamo J, Shahjahan M, Lazarus HM, de Lima M, Giralt SA . Comorbidity indices in hematopoietic stem cell transplantation: a new report card. Bone Marrow Transplant 2005; 36: 475\u2013479.","journal-title":"Bone Marrow Transplant"},{"key":"BF1705486_CR31","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1182\/blood-2004-02-0545","volume":"104","author":"ML Sorror","year":"2004","unstructured":"Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. Blood 2004; 104: 961\u2013968.","journal-title":"Blood"},{"key":"BF1705486_CR32","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","volume":"106","author":"ML Sorror","year":"2005","unstructured":"Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood 2005; 106: 2912\u20132919.","journal-title":"Blood"},{"key":"BF1705486_CR33","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jama.279.15.1187","volume":"279","author":"SK Inouye","year":"1998","unstructured":"Inouye SK, Peduzzi PN, Robison JT, Hughes JS, Horwitz RI, Concato J . Importance of functional measures in predicting mortality among older hospitalized patients. JAMA 1998; 279: 1187\u20131193.","journal-title":"JAMA"},{"key":"BF1705486_CR34","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1200\/JCO.1998.16.4.1582","volume":"16","author":"M Extermann","year":"1998","unstructured":"Extermann M, Overcash J, Lyman GH, Parr J, Balducci L . Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998; 16: 1582\u20131587.","journal-title":"J Clin Oncol"},{"key":"BF1705486_CR35","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","volume":"185","author":"S Katz","year":"1963","unstructured":"Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW . Studies of illness in the aged. The index of ADL: a standardized measure of biological and psychosocial function. JAMA 1963; 185: 914\u2013919.","journal-title":"JAMA"},{"key":"BF1705486_CR36","first-page":"609","volume":"24","author":"MP Lawton","year":"1988","unstructured":"Lawton MP . Scales to measure competence in everyday activities. Psychopharmacol Bull 1988; 24: 609\u2013614.","journal-title":"Psychopharmacol Bull"},{"key":"BF1705486_CR37","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1200\/JCO.2002.20.2.494","volume":"20","author":"L Repetto","year":"2002","unstructured":"Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002; 20: 494\u2013502.","journal-title":"J Clin Oncol"},{"key":"BF1705486_CR38","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1111\/j.1532-5415.2005.53501.x","volume":"53","author":"M Cesari","year":"2005","unstructured":"Cesari M, Kritchevsky SB, Penninx BW, Nicklas BJ, Simonsick EM, Newman AB et al. Prognostic value of usual gait speed in well-functioning older people \u2013 results from the Health, Aging and Body Composition Study. J Am Geriatr Soc 2005; 53: 1675\u20131680.","journal-title":"J Am Geriatr Soc"},{"key":"BF1705486_CR39","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJM199503023320902","volume":"332","author":"JM Guralnik","year":"1995","unstructured":"Guralnik JM, Ferrucci L, Simonsick EM, Salive ME, Wallace RB . Lower-extremity function in persons over the age of 70 years as a predictor of subsequent disability. N Engl J Med 1995; 332: 556\u2013561.","journal-title":"N Engl J Med"},{"key":"BF1705486_CR40","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1046\/j.1532-5415.2003.51104.x","volume":"51","author":"S Studenski","year":"2003","unstructured":"Studenski S, Perera S, Wallace D, Chandler JM, Duncan PW, Rooney E et al. Physical performance measures in the clinical setting. J Am Geriatr Soc 2003; 51: 314\u2013322.","journal-title":"J Am Geriatr Soc"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705486","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705486.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705486.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T09:08:20Z","timestamp":1707210500000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705486"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9,4]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006,11,1]]}},"alternative-id":["BF1705486"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705486","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,9,4]]},"assertion":[{"value":"24 July 2006","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}